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↑What is “already known” in this topic: 
Health care associated infection (HCAI) presents a major prob-
lem for patient safety and could lead to prolonged hospitaliza-
tion, long-term disability, high costs for patients and their fami-
lies, and excess deaths.   
→What this article adds: 
Amino-terminated PAMAM-G6 dendrimer is an effective an-
timicrobial agent against common Gram-negative and Gram-
positive pathogens. Hence, PAMAM-G6 could be an excellent 
candidate for a new class of antimicrobial compounds and 
could be incorporated to combat dominant bacteria in health 
care centers.  
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Abstract 
    Background: Nanoscale poly (amidoamine) dendrimers have been investigated for their biological demands, but their antibacterial 
activity has not been widely discovered. Thus, the sixth generation of poly (amidoamine) dendrimer (PAMAM-G6) was synthesized 
and its antibacterial activities were evaluated on Gram-negative bacteria; P. aeruginosa, E. coli, A. baumannii, S. typhimurium, S. dys-
enteriae, K. pneumoniae, P. mirabilis, and Gram-positive bacteria, and S.aureus and B. subtilis, which were isolated from different 
clinical specimens and standard strains of these bacteria. 
   Methods: In this study, 980 specimens including urine (47%), blood (27%), sputum (13%), wounds (8%), and burns (5%) were 
collected from clinical specimens of 16 hospitals and clinics in city of Sabzevar, Iran. Then, the target bacteria were isolated and iden-
tified using standard methods. Minimum inhibitory concentration and minimum bactericidal concentrations against Gram-positive and 
Gram-negative bacteria were determined according to guidelines described by clinical and laboratory standards institute (CLSI). 
Standard discs were prepared using 0.025, 0.25, 2.5, and 25 μg/mL concentrations of PAMAM-G6 on Mueller-Hinton agar plates to 
determinate the zone of inhibition. The cytotoxicity of PAMAM-G6 dendrimer was evaluated in HCT116 cells by MTT assay. 
   Results: The most important isolated bacteria were E. coli (23.65%), S. aureus (24.7%), P. aeruginosa (10.49%), B. subtilis (7.7%), 
S. typhimurium (8.87%), A. baumannii (7.02%), K. pneumoniae (7.1%), P. mirabilis (6.46%), and S. dysenteriae (3.6%). Moreover, it 
was found that poly (amidoamine)–G6 exhibited more antibacterial efficacy on standard strains than isolated bacteria from clinical 
samples (p<0.05). The cytotoxicity of PAMAM-G6 to the cells showed that cytotoxicity depended on the concentration level and ex-
posure time. 
   Conclusion: The PAMAM-G6 dendrimer showed a positive impact on the removal of dominant bacterial isolated from clinical spec-
imens and standard strains.  
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Novel antibacterial, Synthesis 
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Introduction 
Health care-associated infections (HCAI) are a common 
cause of morbidity and mortality and are considered to be 
one of the most adverse events in health care. Also, these 
infections prolong hospitalization, require further exten-
sive diagnostics and treatment, and are associated with 
additional costs (1). The failure of treatment for these in-
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fections is primarily due to the emergence of multidrug-
resistant strains (MDR), which is a worldwide health care 
concern (2). Approximate ly 90% of HCAI are caused by 
bacteria (3). The most important MDRs associated with 
these infections are methicillin resistant S. aureus (4), 
extended-spectrum beta-lactamase-producing E. coli (5), 
carbapenemase resistant A. buamanii (2), and P. aeru-
ginosa (6). Therefore, considering the increasing preva-
lence of nosocomial infection by strains of MDR, the dis-
covery and development of novel antibacterial agents, 
particularly those with structures and mechanisms of ac-
tion different from traditional antibiotics, and a low poten-
tial to induce antibiotic resistance, now more than ever 
there is a need to control and treat health care- associated 
infections. Recently, the rapid growth in nanotechnology 
has spurred significant interest in the environmental appli-
cations of nanoparticles (NPs). NPs are excellent adsor-
bents, catalysts, and sensors due to their large specific 
surface area and high reactivity (7). More recently, several 
natural and engineered NPs including dendrimer NPs (8, 
9), copper oxide (10), and zinc oxide (11) NPs have also 
been shown to have strong antimicrobial properties. How-
ever, dendrimers are a relatively new class of regularly 
branched macromolecules with unique structure and topo-
logical features that have emerged as strong antibacterial 
agents. 
A typical dendrimer consists of a core molecule, mon-
omeric branches called dendrons and surface functional 
groups that are able to react with other compounds (12). 
PAMAM dendrimers have been thoroughly explored for 
drug delivery and antimicrobial applications and have 
illustrated promising results, with amino-terminated den-
drimers showing high antibacterial efficacy (13, 14). Their 
high antibacterial activity potential is attributed to the 
electrostatic interaction between the cationic dendrimer 
and the anionic bacteria cell surface with resultant disrup-
tion of the lipid bilayer, consequent cell lysis, and death. 
Thus, dendrimer biocides may be beneficial with respect 
to activity, localization in specific organs, reduced toxici-
ty, and increased duration of action (13). An increase in 
the generation of PAMAM dendrimers is followed by a 
double increase in the number of functional amine groups 
in the structure of dendrimer (15). We designed a concep-
tional scheme of PAMAM-G6 dendrimer, which shows 
the number of functional amine groups in each generation 
(Fig. 1). Considering the fact that bacteria cause hospital 
infections and also considering the problem of MDR in 
bacteria, evaluating possible antibacterial properties in 
dendrimers and taking advantage of their ability as an 
antibacterial and antiseptic can be a research priority .The 
present study was conducted to determine the antibacterial 
properties of PAMAM-G6 dendrimer to remove the iso-
lated bacteria from clinical specimens and standard strains 
bacteria. Overall, all the dominant bacteria related to 
HCAI have been investigated in the current study. 
 
Methods 
Sampling and target bacteria 
In this study, sampling was performed in 16 hospitals 
and clinics in the city of Sabzevar, Iran, during August 
2015 and May 2016. In total, 980 clinical samples includ-
ing urine (47%), blood (27%), sputum (13%), wounds 
(8%), and burns (5%) were collected from hospitals and 
clinics. Then, the samples were transferred into medical 
microbiology laboratory. Several smears were prepared 
from each sample and Gram and Giemsa staining were 
done simultaneously. Urine Samples were cultured in Mac 
Conkey Agar, blood agar, and Eosin methylene blue agar 
(EMB). Blood cultures of tryptic soy broth (TSB), Cas-
taneda medium, and lysis centrifuge method were used. 
Also, Mac Conkey Agar and blood agar were used for 
sputum culture, and wounds samples were cultured in 
blood agar and chocolate agar. After 24 hours of incuba-
tion at 37°C, differential catalase, oxidase, coagulase, in-
dole, MRVP, TSI, SIM, citrate, and urease tests were per-
 
Fig. 1. Conception of PAMAM-G6 dendrimer 
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3 
formed to identify the bacterial species. The isolated bac-
teria included Gram-negative bacteria; P. aeruginosa, E. 
coli, A. baumannii, S. typhimurium, S. dysenteriae, K. 
pneumoniae, P. mirabilis, Gram-positive bacteria, and S. 
aureus and B. subtilis. Standard strains used in this study 
were E. coli ATCC 25922, P. aeruginosa ATCC 27853, 
A. baumannii ATCC 17957, S. typhimurium ATCC 
19430, S. dysenteriae ATCC 13313, K. pneumoniae 
ATCC 1705, P. mirabilis ATCC 29906, S. aureus ATCC 
25923, and B. subtilis ATCC 23857, which were provided 
by Iranian Research Organization for Science and Tech-
nology (IROST) and Pasteur Institute of Iran. Before use, 
all bacteria were cultured on specific media. 
 
Synthesis and properties of antimicrobial agent 
Tomalia’s divergent growth approach is the most com-
mon method to synthesize ethylenediamine core PAMAM 
dendrimers (16). PAMAM-G6 was synthesized following 
a 2-step process, involving Michael addition of a suitable 
amine initiator core with methyl acrylate (MA), and ex-
haustive amidation of the resulting esters with large ex-
cess of ethylenediamine (EDA), reported elsewhere (17). 
Briefly, ethylenediamine (10.0 g, 0.166mol) was dissolved 
in 100 mL methanol in a 1-l round-bottomed flask. Methyl 
acrylate (94.6 g, 0.751mol) was added at 40 0C and stirred 
for 24 hours in the presence of nitrogen exposure. Excess 
methyl acrylate was removed under vacuum condition at 
room temperature. A Michael addition between the amine 
and the acrylate yielded a product bearing 4 terminal me-
thyl ester groups, defined as the G0.5 PAMAM. Subse-
quently, ethylenediamine (120 g, 2.00 mol) was dissolved 
in methanol and added to the G0.5 PAMAM. Then, a 
product bearing 4 terminal amino groups was obtained 
and defined as the G1 PAMAM after stirring for 48 hours 
in the presence of nitrogen. Moreover, by removing ex-
cess reactants using vacuum distillation, seventh genera-
tion PAMAM dendrimers was synthesized through repeat-
ing the above cycle. The chemical formula of PAMAM-
G6 is C2542H5088N1018O508, molecular weight equal to 
60713 g/mol, and the number of terminal amine groups is 
256. Fourier transform infrared (FTIR, TENSOR 27 FTIR 
spectrometer, Bruker, Germany) was used to clarify the 
structural behavior of dendrimer on the molecular level. 
The samples were mixed with potassium bromide (KBr) 
powder, and then the mixtures were made into pellet un-
der high pressure. The sample pellet was scanned from 
400 to 4000 cm-1. Pure KBr acted as blank. Morphology 
and size distribution of PAMAM-G6 was analyzed using 
transmission electron microscopy (TEM, Philips CM 30). 
For the TEM investigations, the samples were dispersed in 
ethanol and deposited by placing 2 drops of NPs suspen-
sion onto carbon-covered copper-grids, followed by dry-
ing at room temperature. 
 
Antimicrobial susceptibility testing 
Serial dilution of antimicrobial agent was prepared with 
using sterile distilled water to assess the antimicrobial 
activity of dendrimer. Clinical and Laboratory Standards 
Institute (CLSI) determined the antimicrobial activity of 
dendrimer by calculating minimum inhibitory concentra-
tion (MIC) and minimum bactericidal concentrations 
(MBC) using the serial dilution method (18). Also, disc 
diffusion method was used to determinate the zone of in-
hibition. 
 
Disc diffusion method 
A bacteria culture that has been adjusted to 0.5 McFar-
land standard was evenly applied to Mueller-Hinton agar 
(MHA) plates using a sterile swab. The volume of 25 μL 
of antibacterial agent in different concentrations (0.025, 
0.25, 2.5 and 25 μg/mL) was impregnated to standard 
blank disc (6 mm in diameter). The discs were dried for 
30 minutes and placed on the MHA seeded with the target 
culture and were incubated at 37°C for 24 hours. 
 
Experiments of MIC and MBC  
To determine the exact amount of MIC and MBC of 
bacteria, experiments with different concentrations (0.025, 
0.25, 2.5, 25, 50, 100 and 200µg/ml) of antimicrobial 
agent were conducted. Tubes containing 10 mL of nutrient 
broth (consisting of 108CFU/mL of bacteria and different 
concentrations of dendrimer) incubated in optimal condi-
tions. 
The positive control contained bacteria, with no den-
drimers. Also, the negative control contained dendrimers 
in the absence of bacteria. A tube with the lowest concen-
tration of antimicrobial agent and no bacterial growth was 
reported as MIC. To determine MBC, a loop of each tube 
with no growth transferred to nutrient agar plates and in-
cubated in optimal conditions. A plate with no bacterial 
growth was taken as the MBC value. 
 
Cell cytotoxicity detection by MTT assay 
Cytotoxicity assessment was performed by MTT assay 
in HCT116cells (19) ( human intestinal cancer cell line), 
which was purchased from the Pasteur Institute Cell Bank 
of Iran (http://ncbi.pasteur.ac.ir/). Briefly, 5000 cells sus-
pended in 96-well plates diluted in 100 μL RPMI 1640 
media (Invitrogen, Carlsbad, CA) were supplemented 
with10% heat-inactivated fetal bovine serum (FBS, Invi-
trogen, Carlsbad, CA), and 100 mg/mL penicillin-
streptomycin (Invitrogen, Carlsbad, CA) at 37 °C in a 
humidified atmosphere containing 5 % CO2. After 24 
hours that all cells were attached to the baseline, 100 μL 
of medium containing different concentration of PA-
MAM-G6 (5, 10, 20, 40, 60, 80 and 100 µg/mL) were 
added to each determined well and incubated in above 
conditions for 48 and 72 hours. One of the seeded wells in 
each repeat was used as a control in the absence of PA-
MAM-G6 dendrimer. After incubation, 20 μL containing 
5 mg/mL MTT were added to the wells and incubated 
again for 4 hours. During this time, the MTT (yellow te-
trazolium salt) was enzymatically converted into the pur-
ple formazan precipitate by viable cells, and the concen-
tration of formazan showed the proportion of viable cells. 
Subsequently, all media were aspirated from the cells, 
then, 150 μL of DMSO was added to dissolve the forma-
zan. Finally, absorbance was detected at 490 nm wave-
length by ELISA plate reader. 
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Data analysis  
Statistical analysis was performed using Mann-Whitney 
U test analysis. Statistical significance was set at p<0.05. 
Every experiment was repeated at least 3 times. 
 
Results 
As demonstrated in Fig. 2, the isolated bacteria were E. 
coli (23.65%), S. aureus (24.7%), P. aeruginosa (10.9%), 
B. subtilis (7.7%), S. typhimurium (8.87%), A. baumannii 
(7.02%), K. pneumoniae (7.1%), P. mirabilis (6.46%), and 
S. dysenteriae (3.6%). Fig. 2 displays that the frequently 
of the isolated bacteria with the highest percentage 
(46.4%) were E. coli, S. aureus, and P. aeruginosa from 
urine and blood samples. In addition, these 3 bacteria were 
present in most urine, blood, sputum, wounds, and burns 
samples. In other words, 59.25% of all isolated species 
belong to these 3 bacteria. FTIR analysis of PAMAM-G6 
NPs was performed to confirm the existence of character-
istic amides, terminal amino, and etc. (Fig. 3). Results in 
Table 1 demonstrate the corresponding functional groups 
of the wavelengths, which are indicated in Fig. 3. The 
morphology and diameter of PAMAM-G6 NPs were stud-
ied by TEM as shown in Fig. 4. PAMAM-G6 NPs were 
shown to have a spherical shape with a mean diameter 
size of 20 nm. The results of different concentration of 
PAMAM-G6 dendrimer effect on isolated bacteria and 
standard strain (using disk diffusion method) are presented 
in Tables 2 and 3, respectively. According to the obtained 
results, PAMAM-G6 dendrimer actively inhibited the 
growth of isolated Gram- negative and Gram- positive 
bacteria and standard strains. However, the antibacterial 
activity of PAMAM-G6 on the isolated bacteria was less 
than that on the standard strains, whose difference was 
statistically significant (p‹0.05). The most sensitivity was 
related to P. mirabilis ATCC 29906, S. typhimurium 
ATCC 19430, S. dysenteriae ATCC 13313, and S. aureus 
ATCC 25923 at the concentration of 25 (µg/mL) PA-
MAM-G6 with the inhibition zone of 35, 32, 31, and 30 
mm, respectively. In addition, the least sensitivity was 
 
Fig. 2. Type of Isolated Bacteria and the Frequency Distribution of Each Bacterium in Urine, Blood, Sputum, Wounds and Burns Samples 
 
 
Fig. 3. FTIR Spectra of PAMAM-G6 
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related to A. baumannii at 25 (µg/mL) concentration of 
dendrimer, with 10 mm zone of inhibition. The concentra-
tion of 0.025 (µg/ml) dendrimer had no effect on the stud-
ied bacteria, except S. typhimurium, P. mirabilis, and S. 
aureus. Comparison between MIC and MBC values of 
PAMAM-G6 for isolated bacteria and standard strains are 
presented in Tables 4 and 5, respectively. As can be seen 
in the tables, the maximum amount of MIC and MBC 
were related to isolated bacteria, ie, E. coli and A. bau-
mannii at 25 and 200 µg/mL concentrations of dendrimer, 
respectively. Also, the minimum amount of MIC and 
MBC were related to S. typhimurium ATCC 19430 at 
0.025 and 25 µg/mL concentrations, respectively. The 
effect of PAMAM-G6 on cell viability was assessed using 
MTT assay. This assay measured optical density of differ-
ent concentrations in comparison with the rate of viable 
cells. As displayed in Fig. 5,  there were little cytotoxicity 
effects of PAMAM-G6 with different concentrations in 
HCT 116 cells during 48 hours when no IC50 value was 
obtained (Graph pad prism 6, USA). The cytotoxicity ef-
fects after 72 hours (Fig. 5) were more than 48 hours, with 
no measurable IC50. However, high concentration in 72 
hours had more effects compared to the same concentra-
tion in 48 hours. 
 
 
Table 1. Band position of PAMAM-G6 spectrum 
Wavenumber(cm-1) Spectral assignments 
1025.38 C–O  stretching vibration 
1654.88 C=O stretching (amide I) 
1546.62 N-H bending/C-N stretching (amide II) 
1456.85 H-C-H scissor 
1365.17 H-C-H asymmetric 
2827.55and 2942.81 C-H stretching vibrations 
3416.22cm-1and 3277.82 N-H stretching mode of amineI and amide groups 
 
  
Fig .4. TEM Image of the PAMAM-G6 
Table 2. The Mean Diameter of Inhibition Zone of isolated bacteria VS Different PAMAM-G6 Dendrimer Concentrations 
Dendrimer concentration, μg/ml 
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0.025 0  10 0 0 0 0 9 0 9 
0.25 0  19 0 13 0 0 19 9 10 
2.5 0  21 0 16 13 0 21 9 11 
25 20  31 10 26 27 22 32 17 21 
Table 3. The Mean Diameter of Inhibition Zone Of Standard Strain Bacteria VS Different Concentrations of PAMAM-G6 Dendrimer 
Dendrimer concentration, 
μg/ml 
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0.025 0  14 0 0 0 0 11 0 11 
0.25 0  22 9 19 14 0 21 9 11 
2.5 9  23 13 21 18 9 22 9 17 
25 24  32 20 27 30 22 35 21 30 
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Discussion 
A well-known problem in modern-day hospitalization is 
the occurrence of nosocomial or health care acquired in-
fections caused by multi-resistant pathogens (3). PAMAM 
dendrimers have been investigated for their biological 
applications, but antibacterial activity has not been exten-
sively explored (20). The 980 samples were tested. Fig. 2 
shows the isolated bacteria with the highest frequency 
belonging to E. coli (23.65%), S. aureus (24.7%), and P. 
aeruginosa (10.9%). These 3 bacteria were mostly isolat-
ed from urine and blood samples as 46.4% of these bacte-
ria were isolated from these samples; and of these 9 iso-
lated strains, the highest frequency belonged to these 3 
bacteria (59.25%). Similar results were observed by Sala-
mati et al. (21), as they reported that the most common 
pathogenic organisms were Enterobacter (27%), S. aureus 
(21%), and E.coli (14%). Other studies also reported that 
the most common nosocomial infections were associated 
with E.coli (22), P. aeruginosa, and S. aureus (23). In a 
study conducted by Mazloomi et al. (24), on 172 speci-
mens collected at a children medical center, the most fre-
quent isolated bacteria were S. aureus and P. aeruginosa. 
Ferreira et al. (25) investigated patients’ urine and blood 
specimens and observed that the highest frequency of bac-
teria in urine and blood specimen belonged to E. coli and 
S. aureus, respectively. These pathogens, especially E. 
coli, P. aeruginosa, S. aureus, A. baumannii, and K. 
pneumoniae, are often HCAIs such as Bacterimia, UTIs, 
Table 4. MIC and MBC of the PAMAM-G6 Dendrimer for Isolated Bacteria 
Dendrimer concentration, μg/ml 
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0.025 Growth Growth Growth Growth Growth Growth Growth Growth Growth 
0.25 Growth  MIC Growth MIC MIC Growth MIC MIC MIC 
2.5 Growth  B.S Growth B.S B.S MIC B.S B.S B.S 
25 MIC  MBC MIC B.S B.S B.S B.S B.S B.S 
50 B.S  B.C** B.S B.S MBC B.S B.S MBC B.S 
100 B.S B.C B.S MBC B.C MBC MBC B.C MBC 
200 MBC B.C MBC B.C B.C B.C B.C B.C B.C 
B.S*: Bacteriostatic, B.C**: Bactericide 
 
Table 5. MIC and MBC of the PAMAM-G6 Dendrimer for Standard Strain Bacteria 
Dendrimer concentration, μg/ml 
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0.025 Growth MIC Growth Growth Growth Growth Growth Growth Growth 
0.25 Growth  B.S Growth MIC MIC Growth MIC MIC MIC 
2.5 MIC  MBC MIC B.S B.S MIC B.S B.S B.S 
25 B.S  B.C B.S B.S B.S B.S B.S B.S B.S 
50 B.S  B.C B.S B.S MBC B.S B.S MBC B.S 
100 MBC B.C B.S MBC B.C MBC MBC B.C MBC 
200 B.C B.C MBC B.C B.C B.C B.C B.C B.C 
 
  
Fig. 5. Cytotoxicity of PAMAM-G6 in HCT116 Cells. Cell viability was determined by MTT assay in HCT116 cells in 48 h and 72 h. As depicted 
in this figure there are cytotoxicity effects in different concentration of PAMAM-G6 dendrimer during 48h and 72 h which it is high level in 72 h. 
The IC50 was not determined in both times. The reported values were carried out two independent experiments with 3 repeated times and untreated 
cells were assumed to be viable as control cells. 
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pneumonia, and etc. (26).The size of the inhibition zone 
clearly shows that with increasing concentration of the 
antimicrobial agent, the zone surrounding the disks is ex-
panded, which indicates the power of antimicrobial agent 
at higher concentrations. According to our findings, PA-
MAM derivatives could be considered as an excellent 
candidate for a new class of antimicrobial compounds that 
could be incorporated to combat health care-acquired in-
fections. According to minimum bacteriostatic or bacteri-
cide levels (Tables 4 and 5), it is clear that PAMAM-G6 
has antimicrobial effects and can be used as an antimicro-
bial agent. Previous studies have shown that antimicrobial 
agents cause bacterial cell membrane damage, spatial de-
formation, degradation of bacterial enzymes, and damage 
of chromosome and bacteria cell wall damage. This char-
acter refers to end amine groups in dendrimer structure, 
which interact with the negative charge of the membrane 
or cytoplasm microorganism, causing bacterial cell wall 
damage, and finally, inactivation of bacteria (27). In FTIR 
spectrum of PAMAM-G6 dendrimer (Fig. 3), 9 main 
peaks are detectable at 1025 cm-1, 1365cm-1, 1456 cm-1, 
1546cm-1, 1654cm-1, 2827cm-1, 2942cm-13277cm-1, and 
3416cm-1 , with the last peak being related to N-H stretch-
ing vibration of primary amine. Other main band posi-
tions, based on wave number and their assignments are 
presented in Table 1. Overall, PAMAM-G6 dendrimer is 
an efficient antibacterial agent against both Gram-negative 
and Gram-positive bacteria. Our results are also consistent 
with those of Lopez et al. (28) study. They found that the 
antimicrobial effect of PAMAM dendrimers was modified 
with amine groups on Gram-positive and Gram-negative 
bacteria. Likewise, Xue et al. and Charles et al. found that 
amino-terminated PAMAM G2 and G3 dendrimers pos-
sess significant antibacterial effects against multi-resistant 
strains (12, 29). As shown in Tables 2 to 5, E. coli, P. ae-
ruginosa, and A. baumannii had a higher resistance than 
other studied bacteria. Intrinsic and acquired resistance of 
these bacteria against the antibacterial agent can be at-
tributed to the possible effect of lower concentrations of 
dendrimer PAMAM-G6 on the bacteria such as E. coli, P. 
aeruginosa (30), and A. baumannii (31) than other target 
bacteria. Mihani. et al. indicated that P. aeruginosa were 
resistant against ciprofloxacin (67%), ceftazidime (71%), 
and imipenem (41%) (32). Mohammadimehr et al. (33), 
also, showed that E. coli has a high resistance against am-
picillin, amikacin and piperacillin inoculated discs. The 
findings of the present study are consistent with their re-
sults. The antibacterial activity of PAMAM-G6 on the 
isolated bacteria was less than that on the standard strains 
(Tables 2-5). For example, according to Table 4 and 5, the 
MIC of PAMAM-G6 related to E. coli and A. baumannii 
was 25μg/mL and the MIC of PAMAM-G6 was related to 
E. coli ATCC 25922, and A. baumannii ATCC 17957 was 
2.5μg/mL. High resistance of bacteria isolated from hospi-
tal than standard strains can be attributed to the acquired 
resistance. Many studies also confirm that most bacteria in 
hospitals have been resistant towards most anti-bacterial 
materials. According to reports, most of A. baumannii 
isolated from clinical specimens were resistant to ciprof-
loxacin positions in the top 85% (34). A study conducted 
to evaluate the resistance of P. aeruginosa towards 
ceftazidime showed that in Lithuania 78.9% (35) has de-
veloped resistance to ceftazidime. The diameter of inhibi-
tion zone for S. typhimurium, P. mirabilis, and S. aureus 
was also observed at the concentration of 0.025 µg/mL of 
dendrimer PAMAM-G6 (Tables 3-4). The study conduct-
ed by Izanlo et al. (36) on the effect of PAMAM-G4 den-
drimer on E. coli, Enterobacter cloacae, B. subtilis and S. 
aureus by means of disc diffusion method concluded that 
concentration of 0.05 µg/mL has no effect on these bacte-
ria and also they found that the antibacterial effect of 
PAMAM-G4 occurs at higher concentrations. Izanlo et al. 
(37) examined the effect of dendrimer PAMAM-G4 on 
Klebsiella oxytoca, P. mirabilis, and P. aeruginosa using 
disc diffusion method and found that concentrations of 
0.5, 5, and 50 µg/mL of PAMAM-G4 have no effect on 
these selected bacteria. Perhaps, the higher antibacterial 
effect of dendrimerPAMAM-G6, compared with lower 
generation dendrimers, can be attributed to high density, 
ordered and hyperbranching structure, high spatial void 
between branches, large number of terminal functional 
groups, and relatively large molecular size of PAMAM-
G6 (20).These characteristics lead to highly specific area 
in dendrimer PAMAM-G6, which causes higher activity 
of dendrimers in the surface of culture and higher effi-
ciency at lower concentrations. However, most important-
ly, it is the number of terminal amine groups of dendrimer 
for generation 4 is 64, while the number of terminal amine 
groups for PAMAM-G6 is 256 (38). These functional 
groups are adsorbed on the bacterial cell surfaces, diffused 
through the cell wall, and bonded to cytoplasmic mem-
brane; and as a result, release electrolytes such as potassi-
um ions and phosphate from the cell and also nucleic ma-
terials such as DNA and RNA due to disruption and disin-
tegrate of the cytoplasmic membrane. Therefore, it is pro-
posed that the antibacterial property of dendrimers  be 
mediated  by disrupting the bacterial outer and inner 
membrane by terminal amine groups (27). We also meas-
ured the cytotoxicity of PAMAM-G6 on the HCT 116 cell 
line, and the data revealed that the cytotoxicity will be 
increased in cells at higher concentrations and in long-
term treatments. Mukherjee et al. studied cytotoxicity in 
different generations of PAMAM dendrimers with variety 
of doses. They found that increasing the dose of these 
dendrimers cause a decrease in the percentage of healthy 
and early apoptotic cells. They also demonstrated that the 
systematic mechanism in mammalian cells leads to cyto-
toxicity in various exposures of different generations of 
dendrimers. In line with a recent study, our data revealed a 
reduction in cell viability although the dose and exposure 
time are 2 important factors. This result is consistent with 
a study that found PAMAM could lead to the formation of 
nanoscale holes in eukaryotic membranes at high concen-
trations (39). Increasing the number of surface amino 
groups in the dendrimers and zeta potential may give rise 
to toxicity after increasing generation and diameter (19). 
 
Conclusion 
This study evaluated the antibacterial effects of PA-
MAM-G6 on the isolated bacteria from clinical specimens 
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and standard strains using MIC, MBC, and disc diffusion 
method. The highest number of isolated bacteria was re-
lated to E. coli (23.65%), S. aureus (28.7%), and P. aeru-
ginosa (10.9%). In this study, we found that amino-
terminated PAMAM-G6 dendrimer is an effective antimi-
crobial agent against common Gram-negative and Gram-
positive pathogens. Bacteria origination is one of the im-
portant variables affecting the performance of PAMAM-
G6. The antibacterial activity of PAMAM-G6 on the iso-
lated bacteria was less than that on the standard strains. 
Although increasing the concentration of PAMAM-G6 
improves removal efficiency, their cytotoxicity in mam-
malian cells has to be considered at higher concentrations. 
However, the low levels have relatively high antibacterial 
effects on Gram- negative and Gram- positive bacteria. A. 
baumannii has the least sensitivity to PAMAM-G6, where 
P. mirabilis ATCC 29906, S. typhimurium ATCC 19430, 
S. dysenteriae ATCC 13313, and S. aureus ATCC 25923 
have the highest sensitivity. These findings indicated that 
PAMAM-G6 could be an excellent candidate for a new 
class of antimicrobial compounds and could be incorpo-
rated to combat dominant bacteria in health care centers. 
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